RF
EW icon

Robbins Farley’s Edwards Lifesciences EW Stock Holding History

Robbins Farley’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29M Buy
25,269
+1,005
+4% +$84.2K 0.88% 47
2026
Q1 		$1.94M Buy
24,264
+15
+0.1% +$1.24K 0.86% 44
2025
Q4 		$2.07M Sell
24,249
-3,621
-13% -$297K 0.94% 41
2025
Q3 		$2.17M Sell
27,870
-84
-0.3% -$6.56K 0.9% 43
2025
Q2 		$2.19M Sell
27,954
-391
-1% -$29.2K 1.02% 39
2025
Q1 		$2.05M Sell
28,345
-17
-0.1% -$1.22K 1.09% 41
2024
Q4 		$2.1M Buy
28,362
+258
+0.9% +$18.1K 1% 42
2024
Q3 		$1.85M Buy
28,104
+8,335
+42% +$606K 0.93% 46
2024
Q2 		$1.83M Buy
19,769
+1,110
+6% +$98.3K 0.97% 43
2024
Q1 		$1.78M Sell
18,659
-995
-5% -$83.6K 0.94% 45
2023
Q4 		$1.5M Buy
19,654
+5,436
+38% +$378K 0.9% 49
2023
Q3 		$985K Buy
14,218
+941
+7% +$75.6K 0.67% 52
2023
Q2 		$1.25M Buy
13,277
+5,029
+61% +$437K 0.87% 47
2023
Q1 		$682K Buy
8,248
+179
+2% +$14.1K 0.46% 52
2022
Q4 		$602K Sell
8,069
-14,238
-64% -$1.1M 0.47% 48
2022
Q3 		$1.84M Sell
22,307
-301
-1% -$29K 1.51% 30
2022
Q2 		$2.15M Sell
22,608
-1,809
-7% -$187K 2.24% 21
2022
Q1 		$2.87M Buy
+24,417
New +$2.74M 2.16% 19
2021
Q4 		– Sell
-24,250
Closed -$2.75M – 175
2021
Q3 		$2.75M Buy
+24,250
New +$2.77M 2.02% 21
2021
Q2 		– Sell
-26,423
Closed -$2.39M – 117
2021
Q1 		$2.39M Buy
26,423
+107
+0.4% +$9.05K 2.1% 27
2020
Q4 		$2.4M Buy
+26,316
New +$2.18M 2.36% 18

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robbins Farley's EW Position: Q2 2026 in Review

Robbins Farley increased its Edwards Lifesciences (EW) stake by 4.1% in Q2 2026, buying an estimated $84.2K and bringing the position to 25,269 shares worth $2.29M. The position accounts for 0.88% of the portfolio, ranked #47.

Robbins Farley first reported a position in EW in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.87M in Q1 2022. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Robbins Farley held 25,269 shares of Edwards Lifesciences worth $2.29M as of Q2 2026.
  • Robbins Farley bought 1,005 Edwards Lifesciences shares in Q2 2026, an estimated $84.2K.
  • Edwards Lifesciences made up 0.88% of Robbins Farley's portfolio in Q2 2026, its #47 holding.
  • Robbins Farley first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 21 quarters since.
  • Robbins Farley's Edwards Lifesciences position peaked at $2.87M in Q1 2022.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Robbins Farley's 13F filing for Q2 2026, filed 23 Jul 2026.